Table of Content


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Service Type
3.2. Snippet by Phase
3.3. Snippet by Area
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Improving the supply chain for mRNA vaccine delivery in clinical trials
4.1.2. Restraints
4.1.2.1. Challenges in the clinical trial supply chain
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. SWOT Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Service Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
7.1.2. Market Attractiveness Index, By Service Type
7.2. Manufacturing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Packaging and Labeling
7.4. Storage and Distribution
7.5. Comparator Sourcing
7.6. Others
8. By Phase
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
8.1.2. Market Attractiveness Index, By Dosage Form
8.2. Phase I*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Phase II
8.4. Phase III
8.5. Phase IV
9. By Area
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
9.1.2. Market Attractiveness Index, By Area
9.2. Cardiovascular Diseases*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Respiratory Diseases
9.4. CNS and Mental Disorders
9.5. Oncology
9.6. Others

10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Pharmaceutical and Biotechnology Companies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Contract Research Organizations (CROs)
10.4. Research Institutes and Academic Medical Centers
10.5. Medical Device Companies
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Phase
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Area
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Parexel International (MA) Corporation*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Catalent, Inc.
13.3. Marken
13.4. Piramal Pharma Solutions
13.5. United Parcel Service of America, Inc.
13.6. FedEx
13.7. Movianto
13.8. Packaging Coordinators Inc.
13.9. Biocair
13.10. ICON plc
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us